Phase I Trial of Rituximab, Cladribine and Temsirolimus (RCT) for Initial Therapy of Mantle Cell Lymphoma

被引:2
作者
Inwards, David J. [1 ]
Fishkin, Paul [2 ]
LaPlant, Betsy R. [3 ]
Drake, Matthew T. [4 ]
Kurtin, Paul
Nikcevich, Daniel [5 ]
Wender, Donald [6 ]
Lair, Bradley [7 ]
Witzig, Thomas E. [1 ]
机构
[1] Mayo Clin, Div Hematol, Rochester, MN USA
[2] Onc Heme Associates, Peoria, IL USA
[3] Mayo Clin, Div Biostat, Rochester, MN USA
[4] Mayo Clin, Dept Med, Div Endocrinol, Rochester, MN USA
[5] Essentia Duluth Clin, Duluth, MN USA
[6] Siouxland Hematol Oncol, Sioux City, IA USA
[7] Iowa Oncol Res Assoc, Des Moines, IA USA
关键词
D O I
10.1182/blood.V120.21.3661.3661
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
3661
引用
收藏
页数:2
相关论文
empty
未找到相关数据